Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

PLSE Equity Alert: ROSEN, A Top Ranked Investor Law Firm, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile February 24, 2022

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)

Business Wire February 24, 2022

PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

PR Newswire February 24, 2022

ALERT: Investors in Pulse Biosciences, Inc. With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE

Business Wire February 23, 2022

Investor Action Notice: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 23, 2022

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

PR Newswire February 22, 2022

Investor Action Alert: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 22, 2022

PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

Business Wire February 22, 2022

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)

Business Wire February 22, 2022

Shareholder Alert: Robbins LLP Reminds Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders

Business Wire February 21, 2022

PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

Business Wire February 21, 2022

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Business Wire February 21, 2022

DEADLINE: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE

PR Newswire February 19, 2022

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Business Wire February 18, 2022

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Business Wire February 18, 2022

PULSE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm

Business Wire February 17, 2022

ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE

Business Wire February 17, 2022

(PLSE) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Pulse Biosciences Class Action Lawsuit

Newsfile February 17, 2022

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors

Business Wire February 17, 2022

PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Pulse Biosciences, Inc.

Business Wire February 17, 2022